Janet Woodcock, a top official at the Food and Drug Administration, will retire in 2024 after 37 years of service. Having acted as interim commissioner before Robert Califf took office in 2022, Woodcock was once considered a likely candidate for full-time commissioner. During her tenure, she faced controversy over the approval of opioid painkillers and drugs such as Aduhelm and Exondys.
What’s Next for Healthcare Cybersecurity After a Tumultuous 2024?
Cybersecurity breaches in the healthcare sector are increasing, with ransomware and data exfiltration attacks becoming more frequent. In response, Chief Information Security Officers are putting
